3D printing for tiny blood vessels could help bring an end to animal drug testing

[Pelican Press 0]

This is the hidden content, please

• Sign In
• or
• Sign Up

3D printing for tiny blood vessels could help bring an end to animal ***** testing

Preparation of branched microvasculature. a. Scheme and fluorescent images of extraction and perfusion process. Scale bar 200 μm; b. 3D confocal epifluorescence images of HUVECs cells lining the microchannel walls. Scale bar 200 μm; c. Fluorescent image of HUVECs in 70 μm microvasculature. Inserted picture is a zoom-in image of microvasculature. Scale bar 200 μm; d. Confocal epifluorescence images of liver tissue construct with branched microvasculature. Red: CellTracker Red CMTPX dye labeled HepaRG cells. Green: CellTracker Green CMFDA dye labeled HUVEC cells. Scale bar 1 mm. Credit: Angewandte Chemie International Edition (2024). DOI: 10.1002/anie.202417510

A study that harnesses a pioneering 3D printing technique to create tiny human blood vessel structures could eventually help end the use of animals to test new drugs.

The research, published in the journal

This is the hidden content, please

• Sign In
• or
• Sign Up

, focuses on crafting microvasculature—small vessels critical for tissue health—that measure just 70 micrometers, smaller than a human hair.

The new method—called PRINCESS (PRINting Cell Embedded Sacrificial Strategy)—uses a special type of DNA hydrogel as a biolubricant, to successfully print the smallest ever microvasculature to date.

Sophisticated screening

The research team, led by the University of Strathclyde, say that being able to print human tissues at scale to create a more sophisticated ***** screening platform could eventually end the use of animals in ***** testing, which isn’t always accurate to show what’s happening in the human body.

With more research, they also say that their model created using human cells could reduce cost and be more effective, saving the global pharmaceutical industry billions of dollars.

Professor Will Shu, Hay Chair and head of a world leading research group at the University of Strathclyde said, “Animal testing is not always a good predictor of human response to a *****, so there is a need to develop a more realistic human testing mechanism, and microvasculature is a key facet of that.

“The ability to build intricate vascular networks is crucial for the creation of thick tissues, one of the grand challenges—or ‘holy grails’—of tissue engineering and regenerative medicine. Our new strategy offers an exciting new way for producing engineered human tissues or mini organs in the lab, that could eventually replace the use of animals.”

Professor Shu says that the technology also offers great potential to create new human ******** models, with promising progress already seen in applications for heart *********, ******* and neurodegenerative conditions such as Parkinson’s.

More information:
Jiezhong Shi et al, Printing Cell Embedded Sacrificial Strategy for Microvasculature using Degradable DNA Biolubricant, Angewandte Chemie International Edition (2024).

This is the hidden content, please

• Sign In
• or
• Sign Up

Provided by
University of Strathclyde, Glasgow

Citation:
3D printing for tiny blood vessels could help bring an end to animal ***** testing (2024, November 29)
retrieved 29 November 2024
from

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.

This is the hidden content, please

• Sign In
• or
• Sign Up

#printing #tiny #blood #vessels #bring #animal #***** #testing

This is the hidden content, please

• Sign In
• or
• Sign Up

This is the hidden content, please

• Sign In
• or
• Sign Up

For verified travel tips and real support, visit: https://hopzone.eu/